215 related articles for article (PubMed ID: 18751340)
1. [Transcranial parenchymal sonography in the diagnosis of Parkinson's disease].
Mijajlović M; Petrović I; Stojković T; Svetel M; Stefanova E; Kostić VS
Vojnosanit Pregl; 2008 Aug; 65(8):601-5. PubMed ID: 18751340
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
[TBL] [Abstract][Full Text] [Related]
3. Substantia nigra hyperechogenicity does not correlate with motor features in Parkinson's disease.
Jesus-Ribeiro J; Sargento-Freitas J; Sousa M; Silva F; Freire A; Januário C
J Neurol Sci; 2016 May; 364():9-11. PubMed ID: 27084206
[TBL] [Abstract][Full Text] [Related]
4. The measuring of substantia nigra hyperechogenicity in an Italian cohort of Parkinson disease patients: a case/control study (NOBIS Study).
Prati P; Bignamini A; Coppo L; Naldi A; Comi C; Cantello R; Gusmaroli G; Walter U
J Neural Transm (Vienna); 2017 Jul; 124(7):869-879. PubMed ID: 28451942
[TBL] [Abstract][Full Text] [Related]
5. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease.
Walter U; Dressler D; Wolters A; Wittstock M; Benecke R
Mov Disord; 2007 Jan; 22(1):48-54. PubMed ID: 17083096
[TBL] [Abstract][Full Text] [Related]
6. [Transcranial sonography of substantia nigra in patients with Parkinson's disease].
Miwa H
Rinsho Shinkeigaku; 2013; 53(11):981-2. PubMed ID: 24291852
[TBL] [Abstract][Full Text] [Related]
7. Transcranial brain sonography in Parkinson's disease with restless legs syndrome.
Kwon DY; Seo WK; Yoon HK; Park MH; Koh SB; Park KW
Mov Disord; 2010 Jul; 25(10):1373-8. PubMed ID: 20544813
[TBL] [Abstract][Full Text] [Related]
8. Effect of Age on Substantia Nigra Hyper-echogenicity in Parkinson's Disease Patients and Healthy Controls.
Toomsoo T; Liepelt-Scarfone I; Berg D; Kerner R; Pool AH; Kadastik-Eerme L; Rubanovits I; Asser T; Taba P
Ultrasound Med Biol; 2019 Jan; 45(1):122-128. PubMed ID: 30482710
[TBL] [Abstract][Full Text] [Related]
9. Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.
Berg D
J Neural Transm (Vienna); 2011 Apr; 118(4):613-9. PubMed ID: 21207077
[TBL] [Abstract][Full Text] [Related]
10. Hyperechogenicity of the substantia nigra in Parkinson's disease.
Ressner P; Skoloudík D; Hlustík P; Kanovský P
J Neuroimaging; 2007 Apr; 17(2):164-7. PubMed ID: 17441838
[TBL] [Abstract][Full Text] [Related]
11. In vivo detection of iron and neuromelanin by transcranial sonography--a new approach for early detection of substantia nigra damage.
Berg D
J Neural Transm (Vienna); 2006 Jun; 113(6):775-80. PubMed ID: 16755382
[TBL] [Abstract][Full Text] [Related]
12. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.
Walter U; Wittstock M; Benecke R; Dressler D
J Neural Transm (Vienna); 2002 Feb; 109(2):191-6. PubMed ID: 12075859
[TBL] [Abstract][Full Text] [Related]
13. Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson's Disease.
Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Tan YY; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Chen SD
J Parkinsons Dis; 2018; 8(2):333-340. PubMed ID: 29614699
[TBL] [Abstract][Full Text] [Related]
14. Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease.
Schweitzer KJ; Brüssel T; Leitner P; Krüger R; Bauer P; Woitalla D; Tomiuk J; Gasser T; Berg D
J Neurol; 2007 May; 254(5):613-6. PubMed ID: 17415511
[TBL] [Abstract][Full Text] [Related]
15. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations.
Okawa M; Miwa H; Kajimoto Y; Hama K; Morita S; Nakanishi I; Kondo T
Intern Med; 2007; 46(18):1527-31. PubMed ID: 17878638
[TBL] [Abstract][Full Text] [Related]
16. Substantia nigra echogenicity is associated with serum ferritin, gender and iron-related genes in Parkinson's disease.
Li K; Ge YL; Gu CC; Zhang JR; Jin H; Li J; Cheng XY; Yang YP; Wang F; Zhang YC; Chen J; Mao CJ; Liu CF
Sci Rep; 2020 May; 10(1):8660. PubMed ID: 32457446
[TBL] [Abstract][Full Text] [Related]
17. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease.
Ruprecht-Dörfler P; Berg D; Tucha O; Benz P; Meier-Meitinger M; Alders GL; Lange KW; Becker G
Neuroimage; 2003 Feb; 18(2):416-22. PubMed ID: 12595195
[TBL] [Abstract][Full Text] [Related]
18. Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study.
Cardaioli G; Ripandelli F; Paolini Paoletti F; Nigro P; Simoni S; Brahimi E; Romoli M; Filidei M; Eusebi P; Calabresi P; Tambasco N
Eur J Neurol; 2019 Nov; 26(11):1370-1376. PubMed ID: 31094036
[TBL] [Abstract][Full Text] [Related]
19. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson's disease.
van de Loo S; Walter U; Behnke S; Hagenah J; Lorenz M; Sitzer M; Hilker R; Berg D
J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1087-92. PubMed ID: 20543186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]